ATE517612T1 - Rabeprazol-formulierung - Google Patents
Rabeprazol-formulierungInfo
- Publication number
- ATE517612T1 ATE517612T1 AT07764889T AT07764889T ATE517612T1 AT E517612 T1 ATE517612 T1 AT E517612T1 AT 07764889 T AT07764889 T AT 07764889T AT 07764889 T AT07764889 T AT 07764889T AT E517612 T1 ATE517612 T1 AT E517612T1
- Authority
- AT
- Austria
- Prior art keywords
- rabeprazole
- formulation
- pharmaceutically acceptable
- pharmaceutical composition
- tablet
- Prior art date
Links
- 229960004157 rabeprazole Drugs 0.000 title abstract 3
- YREYEVIYCVEVJK-UHFFFAOYSA-N rabeprazole Chemical compound COCCCOC1=CC=NC(CS(=O)C=2NC3=CC=CC=C3N=2)=C1C YREYEVIYCVEVJK-UHFFFAOYSA-N 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- ZGDLVKWIZHHWIR-UHFFFAOYSA-N 4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]morpholine Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=C(N2CCOCC2)N=C1 ZGDLVKWIZHHWIR-UHFFFAOYSA-N 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 abstract 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 abstract 1
- 239000000920 calcium hydroxide Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229960001778 rabeprazole sodium Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 159000000000 sodium salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06013440A EP1872778A1 (de) | 2006-06-29 | 2006-06-29 | Stabile pharmazeutische Formulierung enthaltend Rabeprazol-Natrium |
| PCT/EP2007/005691 WO2008000463A2 (en) | 2006-06-29 | 2007-06-27 | Rabeprazole formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE517612T1 true ATE517612T1 (de) | 2011-08-15 |
Family
ID=37398281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07764889T ATE517612T1 (de) | 2006-06-29 | 2007-06-27 | Rabeprazol-formulierung |
Country Status (6)
| Country | Link |
|---|---|
| EP (2) | EP1872778A1 (de) |
| AT (1) | ATE517612T1 (de) |
| AU (1) | AU2007263981B2 (de) |
| ES (1) | ES2370664T3 (de) |
| SI (1) | SI2032126T1 (de) |
| WO (1) | WO2008000463A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102011009223A1 (de) | 2011-01-13 | 2012-07-19 | Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. | Multifunktionelles Kompositmaterial zur Luft- und Abwasserreinigung |
| CN103202818A (zh) * | 2012-01-15 | 2013-07-17 | 山东新时代药业有限公司 | 一种含有右旋雷贝拉唑或其可药用盐的肠溶片剂及其制备方法 |
| MX2024012534A (es) * | 2022-04-19 | 2025-04-02 | Hanmi Pharmaceutical Co Ltd | Composicion farmaceutica que comprende acido acetilsalicilico e inhibidor de la bomba de protones |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2189699A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
| ES2373864T3 (es) * | 1998-04-20 | 2012-02-09 | Eisai R&D Management Co., Ltd. | Composición estabilizada que contiene un compuesto de tipo bencimidazol. |
| CA2517289A1 (en) * | 2003-02-28 | 2004-09-10 | Ranbaxy Laboratories Limited | Stable pharmaceutical composition of rabeprazole and processes for their preparation |
| RU2375048C2 (ru) * | 2003-07-17 | 2009-12-10 | Д-Р Редди'С Лабораторис Инк. | Фармацевтическая композиция с набухающим покрытием |
| EP1696889A1 (de) * | 2003-08-28 | 2006-09-06 | Ranbaxy Laboratories, Ltd. | Pharmazeutische zusammensetzungen von benzimidazol und verfahren zu ihrer herstellung |
| BRPI0509135A (pt) * | 2004-03-26 | 2007-08-28 | Eisai R&D Man Co Ltd | composição farmacêutica de liberação controlada e método para produzir a mesma |
| US20090148519A1 (en) * | 2005-09-29 | 2009-06-11 | Yasuhiro Zaima | Pulsed-release preparation having improved disintegration properties in vivo |
-
2006
- 2006-06-29 EP EP06013440A patent/EP1872778A1/de not_active Ceased
-
2007
- 2007-06-27 AT AT07764889T patent/ATE517612T1/de active
- 2007-06-27 AU AU2007263981A patent/AU2007263981B2/en not_active Ceased
- 2007-06-27 EP EP07764889A patent/EP2032126B1/de not_active Not-in-force
- 2007-06-27 ES ES07764889T patent/ES2370664T3/es active Active
- 2007-06-27 WO PCT/EP2007/005691 patent/WO2008000463A2/en not_active Ceased
- 2007-06-27 SI SI200730761T patent/SI2032126T1/sl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2032126B1 (de) | 2011-07-27 |
| WO2008000463A2 (en) | 2008-01-03 |
| SI2032126T1 (sl) | 2011-12-30 |
| EP1872778A1 (de) | 2008-01-02 |
| ES2370664T3 (es) | 2011-12-21 |
| AU2007263981A1 (en) | 2008-01-03 |
| EP2032126A2 (de) | 2009-03-11 |
| WO2008000463A3 (en) | 2008-03-06 |
| AU2007263981B2 (en) | 2012-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1126116T1 (el) | Φαρμακευτικες συνθεσεις αποτελουμενες απο νιλοτινιμπη | |
| WO2006011159A3 (en) | Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability | |
| ZA200903929B (en) | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor | |
| MX374396B (es) | Rocio de fentanilo sublingual. | |
| TW200833370A (en) | Pharmaceutical composition containing low substituted hydroxypropylcellulose | |
| BRPI0719395C1 (pt) | tablete revestido de filme | |
| WO2008129517A3 (en) | A stabilized delayed release pharmaceutical composition of rabeprazole | |
| DE112007001669A5 (de) | Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptablen Salze zur Herstellung einer pharmazeutischen Zubereitung | |
| NO20082047L (no) | Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme | |
| WO2009140341A3 (en) | Atorvastatin compositions | |
| WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
| WO2008001201A3 (en) | Pharmaceutical compositions of clopidogrel | |
| DE602006004694D1 (de) | Feuchtgranulierungsmethode zur Herstellung pharmazeutischer Aripiprazolzusammensetzungen | |
| BR122016006880B8 (pt) | forma de dosagem contendo pantoprazol como ingrediente ativo | |
| WO2008020314A3 (en) | Statin stabilizing dosage formulations | |
| SI2032126T1 (sl) | Formulacija z rabeprazolom | |
| WO2010137040A3 (en) | Novel pharmaceutical compositions of ranolazine | |
| EA201001871A1 (ru) | Гастрорезистентные пероральные фармацевтические композиции, содержащие дулоксетин или его фармацевтически приемлемые производные | |
| WO2007138462A3 (en) | Aqueous oral formulations of risperidone | |
| WO2009087657A3 (en) | Stable pharmaceutical composition of duloxetine and process for its preparation | |
| ATE508737T1 (de) | Clopidogrel-hydrogensulfat von polymorph 1 form enthaltende pharmazeutische zusammensetzung | |
| ATE474558T1 (de) | Pharmazeutische formulierungen mit irbesartan | |
| WO2008015530A3 (en) | Stable solid oral formulation of pantoprazole | |
| ATE496899T1 (de) | Tetrahydro- und dihydrochinazolinone | |
| ATE530172T1 (de) | Pharmazeutische formulierungen mit clopidogrel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2032126 Country of ref document: EP |